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a  b  s  t  r  a  c  t
In this  study,  a  series  of  mastoparan  analogs  were  engineered  based  on the  strategies  of Ala  and  Lys
scanning  in  relation  to the  sequences  of classical  mastoparans.  Ten  analog  mastoparans,  presenting  from
zero to six Lys  residues  in  their  sequences  were  synthesized  and assayed  for  some  typical  biological  activ-
ities  for this  group  of  peptide:  mast  cell degranulation,  hemolysis,  and  antibiosis.  In relation  to  mast  cell
degranulation,  the  apparent  structural  requirement  to optimize  this  activity  was the  existence  of  one  or
two Lys  residues  at positions  8 and/or  9. In relation  to hemolysis,  one  structural  feature  that  strongly  corre-
lated  with  the potency  of this  activity  was  the  number  of  amino  acid  residues  from  the  C-terminus  of  each
peptide  continuously  embedded  into  the  zwitterionic  membrane  of erythrocytes-mimicking  liposomes,
probably  due  to the  contribution  of this  structural  feature  to  the  membrane  perturbation.  The antibiotic
activity  of mastoparan  analogs  was  directly  dependent  on  the apparent  extension  of  their hydrophilic
surface,  i.e.,  their  molecules  must  have  from  four to  six  Lys residues  between  positions  4 and  11  of  the
peptide  chain  to achieve  activities  comparable  to  or higher  than  the  reference  antibiotic  compounds.  The
optimization  of the  antibacterial  activity  of  the mastoparans  must  consider  Lys  residues  at the positions
4,  5,  7,  8,  9,  and  11  of  the  tetradecapeptide  chain,  with  the  other  positions  occupied  by hydrophobic
residues, and with  the  C-terminal  residue  in the  amidated  form.  These  requirements  resulted  in highly
active  AMPs  with  greatly  reduced  (or  no)  hemolytic  and  mast  cell degranulating  activities.
©  2015  Elsevier  Inc.  All  rights  reserved.ntroductionThe search for new antibiotic substances found an almost
nexhaustible source of potential therapeutic agents amongst
ntimicrobial peptides (AMPs), with sources including insect
∗ Corresponding author at: Center for the Study of Social Insects/Department of
iology, IBRC-UNESP, Avenue 24A, 1515, Bela Vista, Rio Claro 13506 900, SP, Brazil.
el.: +55 19 35264163; fax: +55 19 35348523.
E-mail address: mspalma@rc.unesp.br (M.S. Palma).
ttp://dx.doi.org/10.1016/j.peptides.2015.04.021
196-9781/© 2015 Elsevier Inc. All rights reserved.venoms. Nevertheless, the hidden promise turned into challeng-
ing holdbacks, such as difﬁculties and costs of synthesis of longer
peptide sequences, narrower range of action, sensitivity of the
short peptide chains to the physiological levels of salts, low tox-
icity for the host, and suitability of pharmacokinetic properties
[13,14,18,38,42]. In the venom of wasps, mastoparan peptides rep-
resent good examples of antimicrobial peptides that have been
intensively investigated [4,11,15,39–41]. Mastoparans are poly-
cationic AMPs with 14 amino acid residues amidated at the
C-terminus, with broad action against Gram-positive and Gram-
negative bacteria and yeasts [4,27].
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Typically, mastoparans present three Lys residues at positions
/5 and/or 11/12 [5,26,27,40]. One interesting exception is the pep-
ide EMP-AF, in which Lys residues are at positions 5, 9 and 12 [7].
ilpert et al. [18], working with a complete substitution library of a
odecapeptide derived from bactenecin, showed that certain posi-
ions are more sensitive to substitutions than others and that the
ntroduction of certain amino acid residues, particularly charged
nes, can generate peptides with increased antimicrobial activ-
ty. Kim and Cha [19], using model AMPs composed only of Leu
nd Lys residues, concluded that these peptides display different
ationic distributions and that the dispersion of these amino acid
esidues on the hydrophilic surface is a factor that contributes to
ntimicrobial activity.
It was reported that the antimicrobial activities of mastoparan
eptides bearing positive charges at the positions 4/5 and/or 11 to
3 were very active, while peptides presenting positive charges
ocated in the middle of the peptide chain resulted in reduced
ctivity [5,6,8,9]. It was suggested that the positioning of the Lys
esidues at those strategic sites would ﬂank and maintain a sta-
le helical segment, resulting in a more homogeneous hydrophobic
urface in an amphipathic structure, which in turn contributes to
he maximal lytic efﬁciency of the mastoparans. At the same time,
eite et al. [22] demonstrated the interplay between net charge
nd mean hydrophobicity, working with similar mastoparan pep-
ides. These studies lead us to further investigate the role of the
umber and positioning of Lys residues along the peptide chain,
aking into consideration their contribution to the following: (i) the
umber of amino acid residues of the hydrophilic and hydrophobic
urfaces for the mean hydrophobicity per residue; (ii) the posi-
ioning of the peptide in relation to a model bilayer surface; (iii)
he effects of these variables on the classical biological activities of
astoparans.
In this study, a series of novel peptides were engineered, con-
idering the number and the positioning of Lys residues, with the
equences of known mastoparan peptides as a reference. Attempts
ere also made to optimize the antimicrobial activity while reduc-
ng the hemolytic activity and maintaining/reducing mast cell
egranulation. The effects of two different strategies of residue
eplacement were investigated: (i) the individual replacement of
ys residues by Ala, one by one, in a type of Ala scan; and (ii) the
eplacement of Leu or Ala residues by Lys, in a type of Lys scan.
aterials and methods
eptide synthesis and puriﬁcation
The peptides were prepared by step-wise manual solid-
hase synthesis using N-9-ﬂuorophenylmethoxy-carbonyl (Fmoc)
hemistry with Novasyn TGS resin (NOVABIOCHEM, Germany).
ide-chain protective groups included N--trityl for asparagine and
-butoxycarbonyl for lysine. Cleavage of the peptide-resin com-
lexes was performed by treatment with triﬂuoroacetic acid/1,2-
thanedithiol/anisole/phenol/water (82.5:2.5:5:5:5 by volume),
sing 10 mL/g of complex at room temperature for 2 h. After ﬁlter-
ng to remove the resin, anhydrous diethyl ether (SIGMA, USA) at
◦C was added to the soluble material, causing precipitation of the
rude peptide, which was collected as a pellet by centrifugation at
000 × g for 15 min  at room temperature. The crude peptides were
uspended in water and chromatographed under RP-HPLC using
 semi-preparative column (SHISEIDO, Japan; C18, 250 × 10 mm,
 m)  at a ﬂow rate of 2 mL/min in the following isocratic condi-
ions with acetonitrile in water (containing 0.1%(v/v) triﬂuoroacetic
cid): 48% (v/v) for MK578, 47% (v/v) for MK89, 50% (v/v) for MK9,
0% (v/v) for MK5, 55% (v/v) for MK0, 37% (v/v) for MK4589, 39%
v/v) for MK5789, 35% (v/v) for MK58911, 33% (v/v) for MK45789,s 72 (2015) 164–174 165
and 30% (v/v) for MK4578911. The elution was  monitored at 214 nm
using a UV-DAD detector (SHIMADZU, Kyoto, Japan; mod. SPD-
M10A), and each fraction eluted was manually collected into 15 mL
glass vials. The puriﬁed synthetic mastoparan analogs were dried
under vacuum during 18 h at 4 ◦C, and then their weight were deter-
mined in a analytical balance.
The homogeneity and correct sequence of the synthetic peptides
were assessed using a gas-phase sequencer PPSQ-21A (SHIMADZU,
Japan) based on automated Edman degradation chemistry and
ESI–MS analysis.
Liposomes preparation
Phospholipids supplied by Sigma-Aldrich Co. (St. Louis, MO)
were dissolved in chloroform, and ﬁlms were prepared using solu-
tions of 100% egg l--phosphatidylcholine (PC) or 70% PC: 30% egg
l--phosphatidyl-dl-glycerol (PCPG) by evaporating the solvent to
dryness under N2 ﬂux. Small unilamellar vesicles (SUVs) were pre-
pared by hydration of the phospholipid ﬁlms with 5 mM Tris/H3BO3
buffer pH 8.0, containing 0.5 mM EDTA and 150 mM NaF, followed
by sonication with a tip sonicator for 50 min  under refrigeration
by water bath and N2 ﬂux. Then, the preparation was subjected to
11 times extrusion through two  stacked 50 nm pore size polycar-
bonate membranes (Nuclepore Track-etch Membrane, Whatman,
USA), using an Avanti mini-extruder. Large unilamellar vesicles
(LUVs) were prepared by hydration of the ﬁlms with bi-distilled
water at room temperature, followed by 6 times extrusion through
400 nm pore size polycarbonate membranes (Nuclepore Track-etch
Membrane, Whatman) and then 11 times extrusion through two
stacked 100 nm pore size membranes. Both types of vesicles were
prepared to give approximately 10 mM lipids concentration; they
were kept under refrigeration, protected from light and used on the
day of preparation. The sizes of liposomes were conﬁrmed by mea-
surements of dynamic light scattering (DLS) using a Nano Zetasizer
ZS90 (Malvern Instruments, Worcestershire, U.K.).
Secondary structure evaluation through circular dichroism (CD)
To evaluate the conformational changes of the peptides induced
by membrane-mimetic environments, CD spectra were acquired
at 20 M peptide concentration in 2,2,2-triﬂuoroethanol (TFE)/bi-
distilled water (40% v/v), in 8 mM sodium dodecyl sulfate solution
(SDS), in 100 M PC and 100 M PCPG liposomes (SUVs). These
spectra were compared with the spectra obtained in water and
in Tris/H3BO3 buffer containing 150 mM NaF. CD spectra were
recorded from 190 or 200 to 260 nm with a Jasco-710 spectropo-
larimeter (JASCO International Co. Ltd., Tokyo, Japan), which was
routinely calibrated at 209 nm using d-pantolactone solution [20].
Spectra were acquired at 25 ◦C using a 0.5 cm path length cell and
averaged over eight or nine scans at a scan speed of 20 nm/min,
bandwidth of 1.0 nm,  0.5 s response and 0.1 nm resolution. Fol-
lowing baseline correction, the observed ellipticity,  (mdeg), was
converted to mean residue ellipticity, [] (deg/cm2/dmol), using
the following relationship:
[] = 100
(lcn)
,
where l is the path length in centimeters, c is the peptide millimolar
concentration, and n is the number of peptide bonds. Assuming a
two-state model, the observed mean residue ellipticity at 222 nm
([]obs222) was  converted into the -helix fraction (fH) using the
method proposed by Rohl and Baldwin [24,31].
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etermination of the positioning of peptides in proteoliposomes
y mass spectrometry
To access the positioning of the peptide backbone in rela-
ion to the surface of model membranes, electrospray ionization
ass spectrometry (ESI-MS) was used to analyze the hydro-
en/deuterium (H/D) exchange properties of peptides in D2O
olution or incorporated into LUVs (proteoliposomes) diluted
ith D2O. After quenching deuteration by the addition of formic
cid, the H/D exchange was directly analyzed by ESI–MS. The
euterated peptide ions were analyzed under collision induced
issociation (CID) mass spectrometry, which permitted the loca-
ion of deuterons at the amide sites along the peptide backbone.
ntramolecular hydrogen scrambling was investigated both for free
eptides in solution and for their supramolecular structures as pro-
eoliposomes, as described elsewhere [6,34].
Experiments were performed on a triple-quadrupole mass spec-
rometer (Micromass, Altrincham, UK), mod. Quattro-II, equipped
ith a standard ESI source. During all experiments, the source
emperature was maintained at 80 ◦C and the capillary voltage at
.80 kV; a drying gas ﬂow (nitrogen) of 210 L/h and a nebulizer
as ﬂow of 15 L/h were used. The mass spectrometer was cali-
rated with intact horse heart myoglobin and its characteristic
one-voltage-induced fragments; the cone-to-skimmer lens volt-
ge controlling the ion transfer to the mass analyzer was manually
et to 120 V. Before beginning the H/D exchange measurements,
UVs were incubated at 30 ◦C for at least 30 min.
SUVs in the presence or absence of peptides were pre-incubated
or times ranging from 1 to 60 min  at room temperature before
easuring H/D exchange. The suspensions of liposomes in the pres-
nce of peptides were prepared for H/D exchange monitoring as
escribed above, except for replacing bidistilled water with 99%
v/v) D2O (Cambridge Isotopes Laboratories, Inc.). The free peptide
olution was prepared for H/D exchange by adding 5 L of peptide
olution (1.2 g/L) to either 22 L bidistilled water or liposome
uspension and adding 50 L 99% (v/v) D2O following the liposome
re-incubation. The H/D exchange was allowed to proceed for 30
 and then quenched by adjusting the pH to 2.5 by the addition of
 L of 99% formic acid, followed by cooling to 0 ◦C. The solution of
ree peptides or the liposomes/peptide suspension was introduced
nto the mass spectrometer at a ﬂow of 4 L/min with a microperfu-
ion pump (KD Scientiﬁc). Spectra were continuously acquired over
 min  by direct injection of the samples into the ionization source
ystem. Each H/D exchange reaction was performed three times
or each condition, and the tandem mass spectra were individually
cquired for each replicate experiment. The mass-to-charge values
f all ions of interest from each spectrum were used to calculate the
ate values, with their respective standard deviations, and for the
alculation of deuterium incorporation into the peptide. ESI spec-
ra were acquired in continuous acquisition mode, scanning from
/z 200–2500, with a scan time of 7 s. Typical conditions used to
erform the CID MS  experiments were as follows: argon as the colli-
ion gas; capillary voltage of 1.78 kV, cone voltage of 120 V, collision
nergy of 135 eV, collision gas pressure of 4.10−4 mBar and des-
lvation gas temperature of 80 ◦C. In these experiments, the ﬁrst
uadrupole (Q1) was used to select precursor ions, which were frag-
ented in the hexapole (Q2) collision cell, generating product ions
or subsequent mass analysis by the last quadrupole mass analyzer
Q3). Data acquisition was performed in continuous mode, scan-
ing from m/z 40 to the m/z  value of the monoprotonated form
f the peptide [M + H]+, with a scan time of 5 s, and monitored
sing the MassLynx software. Peptide sequences were manually
ssigned from ESI–MS/MS product ion mass spectra. Mass spectro-
etric measurements were begun as quickly as possible (the dead
ime was approximately 90 s), and analyses were performed in MS
nd MS/MS  modes. Each H/D exchange reaction was  performeds 72 (2015) 164–174
ﬁve times for each condition, and the tandem mass spectra were
individually acquired for each replicate experiment. The mass-to-
charge values of all fragment-ions of interest from each spectrum
were used to calculate the rate values with the respective stan-
dard deviations and to calculate deuterium incorporation into the
peptide.
Biological activities
Mast cell degranulation
Mast cell degranulation was determined by measuring the
release of -d-glucosaminidase, which co-localizes with histamine.
Mast cells were obtained by peritoneal washing of Wistar rats with
a solution containing 0.877 g NaCl, 0.028 g KCl, 0.043 g NaH2PO4,
0.048 g KH2PO4, 0.10 g glucose, 0.10 g BSA, 90 mL  2 M CaCl2 solu-
tion, and 50 L Liquemine (heparin, Roche) in 100 mL  water. The
mast cells were incubated in the presence of various peptide
concentrations for 15 min  at 37 ◦C. Then, 50 L of the mast cell
suspensions was added to 50 L of the substrate, which consisted
of 3.4 mg  of p-nitrophenyl-n-acetyl--d-glucosaminidine (Sigma-
Aldrich, St. Louis, MO)  dissolved in 10 mL  of 200 mM sodium citrate
solution at pH 4.5 and incubated for 6 h at 37 ◦C. The reaction
was interrupted by the addition of 150 L of 0.2 M Tris solution;
after centrifugation, the supernatants were sampled for the b-d-
glucosaminidase assay, and the absorbance of the colored product
was assessed at 405 nm in a microtiter plate reader (Biotrack,
Amersham Bioscience). The values were expressed as the mean
percentage of total b-d-glucosaminidase activity from ﬁve exper-
iments with rat mast cell suspensions, in relation to mast cells
lysed by the addition of 0.1% (v/v) Triton X-100 (considered as 100%
reference).
Hemolysis
Five hundred microliters of washed rat red blood cells (WRRBC)
was suspended in 50 mL  of physiological saline solution (0.9% (w/v)
NaCl). Ninety microliters of this suspension was incubated with
10 mL  of peptide solution at different concentrations at 37 ◦C for
2 h. The samples were then centrifuged, and the absorbance of the
supernatants was measured at 540 nm.  The absorbance measured
from lysed WRRBC in the presence of 1% (v/v) Triton X-100 was
considered to be 100%. The results are expressed as the mean ± S.D.
of ﬁve experiments.
Antimicrobial activity
The minimal inhibitory concentrations (MIC) of the peptides
were determined based on methods described by Meletiadis et al.
[25]. The following microorganisms were used: Escherichia coli (CCT
1457), E. coli (ATCC 11775), E. coli (ATCC 25922), Pseudomonas
aeruginosa (ATCC15442), P. aeruginosa (ATCC13388), Salmonella
choleraesuis (ATCC10708), Salmonella typhimurium (ATCC14028),
Staphylococcus aureus (CCT 2580), S. aureus (CCT 6538), S. aureus
(ATCC 25923), Staphylococcus epidermides (ATCC12228), Staphylo-
coccus pneumoniae (ATCC11733), Staphylococcus mutans (AU159),
Bacillus cereus (ATCC11778), Bacillus thuringiensis (ATCC10792),
Enterococcus faucium (CCT5079), Enterococcus hirae (ATCC10541),
Rhodococcus equi (ATCC25729), and Micrococcus luteus (ATCC4698).
The experiment was  performed in 96-well plates. Bacterial cells
were suspended in sterile culture medium; the inoculum size was
1 × 104 cells m/L  in Müller–Hinton broth (DIFCO), conﬁrmed by the
use of the McFarland scale. From this culture, 50 mL was  spread
onto a micro-plate previously containing 50 mL  of Müller–Hinton
broth, resulting in a ﬁnal cell density of 1.5 × 103 cell/mL. Cells
were incubated at 37 ◦C for 18 h in the presence of 100 mL of each
peptide solution, in a concentration range from 0.8 to 50 mg/mL.
After incubation, 10 mL  of a triphenyltetrazolium chloride (TTC)
(MALLINCKRODT) solution (ﬁnal concentration 0.05%, w/v) was
eptides 72 (2015) 164–174 167
a
L
r
t
e
r
w
c
m
R
D
r
t
b
t
i
T
c
m
e
e
i
r
r
w
S
C
m
C
s
t
a
M
M
P
c
p
(

t
m
n
M
n
m
F
(
a
f
a
d
h
p
p
c
n
b
Fig. 1. CD spectra of peptides MK578, MK89 and MK4589 obtained at 20 M and
25 ◦C. (a) MK578 in water, in 8 mM SDS and in 40% TFE solution; MK89 and MK4589
in  8 mM SDS and in 40% TFE solution. (b) MK578 in buffer, in zwitterionic PC SUVsB.M.d. Souza et al. / P
dded to each well plate. The plate was incubated at 37 ◦C for 2 h.
ive colonies reduce TTC to a dark red color, while colonies with
educed respiratory function are unable to perform this reduc-
ion and instead remain unchanged in color. Thus, the results were
xpressed as the MIC  that inhibits all colony-forming units. Chlo-
amphenicol (Sigma-Aldrich) was used as a standard antibiotic, and
ells containing only the culture medium were used as negative
ontrols. The results are expressed as the mean of three experi-
ents.
esults
esign of peptide sequences
To investigate the effect of the number and positioning of Lys
esidues on the secondary structure of the peptides, the interac-
ion of each peptide with the bilayer surface, and the resulting
iological activities, a set of ten tetradecapeptides, amidated at
he C-terminus, were synthesized and puriﬁed; these peptides
ncluded from zero to six Lys residues, at positions from +1 to +7.
able 1 shows the sequences of these peptides, their respective net
harges, and the values of mean hydrophobicity and hydrophobic
oment, calculated according to the consensus scale of Eisenberg
t al. [12]. The nomenclature used to identify the peptides consid-
red their derivation from Mastoparans and the presence of Lys (K)
n the sequence; the numbers represents the positioning of each K
esidue. Thus, the peptide MK578 represents a Mastoparan with K
esidues at positions 5, 7, and 8, while MK0  represents a Mastoparan
ith no K residue in the sequence.
econdary structure evaluation
The secondary structures of the peptides were determined by
D spectroscopy in the presence of water and buffer, in membrane-
imetic environments, and in the presence of model membranes.
omparative spectra of peptides MK578, MK89 and MK4589 are
hown in Fig. 1, while the spectra of remaining peptides and
he respective values of mean residue molar ellipticity at 222 nm
re shown in the supplementary information (Fig. S1). Peptides
K89 and MK4589 present higher intensity spectra at 222 nm than
K578 in the presence of 40% (v/v) TFE, in 8 mM SDS and in 100 M
CPG vesicles, indicating that in these environments, higher heli-
al content was induced. In the presence of 100 M PC vesicles,
eptide MK89, one of the analogues with higher hydrophobicity
Table 1), presents a spectrum compatible with the induction of
-helical structures, while the spectra of MK578 and MK4589 are
ypical of random coil structures, reﬂecting poor binding to the
embrane-mimetic system.
In water, the CD spectra of the peptides show a negative band
ear 200 nm,  indicating a random coil conformation, except for
K0, which has characteristics of -turn structure, showing a
egative band at approximately 220 nm and a positive band of
uch higher intensity at approximately 197 nm (Supplementary
ig. S1). In aqueous solution of 40% (v/v) TFE or in micellar SDS
8.0 mM), the spectra present two negative dichroic bands at 222
nd 208 nm,  which are characteristic of -helical conformation
or most peptides. Slight deviations from these values (219–221
nd 205–209 nm)  were found for MK578 and MK5. Important
eviations were found for the most hydrophobic and the most
ydrophilic peptides, MK0  and MK4578911, respectively (Sup-
lementary Fig. S1). They show certain characteristics of helical
eptides in the presence of 40% (v/v) TFE solution and certain
haracteristics of -turn in the presence of 8 mM SDS, displaying
egative bands, respectively, at 218 nm and 225 nm and positive
ands at 195 nm.  Zwitterionic liposomes were not able to induceat  100 M and in anionic PCPG SUVs at 100 M;  MK89 and MK4589 in PC SUVs at
100 M and in anionic PCPG SUVs at 100 M. No smoothing has been applied.
conformational changes in MK578 and in the hydrophilic pep-
tides (MK4589, MK5789, MK58911, MK45789, MK4578911), which
show random coil conformations, but the analogues MK89, MK9
and MK5  present spectra characteristic of helical peptides. Addi-
tionally, in presence of vesicles, MK0  and MK4578911 present
different secondary structures from the remaining analogues: in
PC and in PCPG vesicles, MK0  shows characteristics of -turn
structures, while MK4578911 shows a random coil conﬁgura-
tion (Supplementary Fig. S1). Anionic liposomes induced -helical
conformation in all other analogues. Values of mean residue
molar ellipticity at 222 nm are shown in Supplementary Table S1
(electronic Supplementary information). Signs of possible peptide
aggregation were found for MK578 in 40% (v/v) TFE, for MK89
and MK9  in PCPG, and for MK5  in PC and in PCPG, as indicated
by the relationship between molar ellipticities at 222 and 208 nm,
[]222 > []208 [3].
From the values of mean residue molar ellipticity at 222 nm,  the
-helix fractions were calculated for all ten MK  peptides (Table 2).
MK4589 is the peptide with the highest ellipticity in 8 mM SDS
and in 40% (v/v) TFE. Most of peptides in this study presented
similar helical content in the presence of SDS or in TFE; only the
peptides MK0, MK578, and MK4578911 presented low -helix con-
tent under these conditions. Peptides MK578, MK4589, MK5789,
MK58911, and MK4578911 (peptide analogs with net charge ≥+5)
168 B.M.d. Souza et al. / Peptides 72 (2015) 164–174
Table 1
Sequences of engineered mastoparans with Lys residues shown in bold face, with respective values of net charge (Q) at physiological pH, mean hydrophobicity per residue
〈H〉  and hydrophobic moment of designed mastoparan analog peptides ().
Peptides Sequences Qa 〈H〉b b
MK578 I N W L K A K K V A G M I L-NH2 +4 0.029 0.104
MK89  I N W L A I A K K V A G M L-NH2 +3 0.126 0.185
MK9  I N W L A I A A K V A G M L-NH2 +2 0.222 0.168
MK5  I N W L K I A A A V A G M L-NH2 +2 0.222 0.163
MK0  I N W L A I A A A V A G M L-NH2 +1 0.319 0.072
MK4589 I N W K K I A K K V A G M L-NH2 +5 −0.087 0.279
MK5789 I N W L K I K K K V A G M L-NH2 +5 −0.067 0.191
MK58911 I N W L K I A K K V K G M L-NH2 +5 −0.067 0.242
MK45789 I N W K K I K K K V A G M L-NH2 +6 −0.184 0.216
MK4578911 I N W K K I K K K V K G M L- +7 −0.280 0.248
a Includes an extra charge due to the amidated C-terminus.
b Calculated according to Eisenberg et al. consensus scale [12].
Table 2
The -helix fraction for the complete series of MK  peptides, calculated according to
a  two-state model [31].
f(H) Water TFE 40% SDS 8 mM PC PCPG
MK578 Rc 0.31 0.25 rc 0.23
MK89 Rc 0.43 0.46 0.18 0.30
MK9  Rc 0.45 0.42 0.29 0.37
MK5  Rc 0.46 0.44 0.37 0.42
MK0  Bt 0.29 Bt bt bt
MK4589 Rc 0.65 0.69 rc 0.26
MK5789 Rc 0.58 0.42 rc 0.22
MK58911 Rc 0.60 0.51 rc 0.26
MK45789 Rc 0.54 0.51 rc 0.19
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c = Random coil; bt = -turn-like structure.
howed selective interaction in relation to the anionic PCPG vesicles
ompared to the zwitterionic PC vesicles, presenting only random
oil under this condition. The lower helical content of most pep-
ides in anionic vesicles compared to SDS micelles may  be due to
nsufﬁcient charge neutralization by the PCPG vesicles.
etermination of the positioning of peptides in proteoliposomes
y mass spectrometry
The interaction of peptides with vesicles was investigated using
 homogeneous population of LUVs presenting a diameter of
30 ± 8 nm.  The binding and positioning of the peptides in rela-
ion to the LUV surface was monitored by ESI–MS/MS through
/D exchange in proteoliposomes. H/D exchange mass spectrom-
try assays can show how the peptide backbone interacts with
embranes [6,34]. In this technique, the site-speciﬁc locations of
euteron positions in the peptide–membrane-mimetic systems are
etermined, indicating which amino acid residues of the peptide
hain are positioned in the inner core of the membrane and which
nes are interacting with the outside medium [34]. In this study, all
he peptides were analyzed in the presence of water, zwitterionic
C vesicles and anionic PCPG vesicles; peptide MK578 is used as
n example in Fig. 2. To save printing space, only the mass spec-
ra of MK578 are shown in the main text, while the spectra of the
ther peptides are presented as electronic supplemental informa-
ion (Supplementary Figs. S2–S10).
Fig. 2A shows the CID spectra for studying the H/D exchange of
K578 in the presence of water, while Fig. 2B and C shows the CID
pectra in the presence of PC and PCPG vesicles and D2O, respec-
ively. In the presence of water, the CID spectrum (Fig. 2A) shows
 clear pattern of fragmentation, with easy interpretations of the
K578 sequence; the pattern of fragmentation of all peptides was
haracterized by the formation of a dipeptide at the N-terminus of
ach peptide. The CID spectrum in the absence of liposomes but in
he presence of D2O is not shown, as all the amino acid residuesNH2
of the sequences became deuterated under this condition in all ten
peptides assayed.
In the presence of PC vesicles, the backbones of residues Ile1,
Ans2, Leu4, Lys5, Ala6, Lys8, Val9, and Ile13 were labeled with
deuterium, identifying their position located outside the bilayer
surface. In the presence of PCPG vesicles, the interaction was
observed to be slightly shallower than in the presence of PC vesicles,
because the backbones of nine residues were labeled (positioned
outside the vesicle membrane): Ile1, Ans2, Leu4, Lys5, Ala6, Val9,
Ala10, Gly11 and Ile13 (Fig. 2B and C). In both environments, the C-
terminus was embedded in the inner core of the membrane (not
deuterated), while the N-terminus was labeled with deuterium,
indicating that this region does not access the interior of the mem-
brane during the H/D exchange process.
Based on the data obtained from the CID MS  spectra of the
remaining peptides (Figs. S2–S10), the pattern of H/D exchange
for each peptide was  interpreted in the presence of water, as well
in the presence of PC and PCPG vesicles; diagrams representing
the interactions of the peptides with the surfaces of the PC and
PCPG membranes are shown in Fig. 3. A common feature amongst
these peptide interactions with both types of vesicles is that their
N-termini residues/regions are exposed to the solvent medium,
while their C-termini residues/regions are embedded in the bilayer
environment. This observation is consistent with the charged
nature of the N-terminal residues, as previously reported for other
mastoparan peptides [34]. The amidation of the C-terminal residues
of mastoparans was also reported to be an important structural
feature in maintaining the helical secondary structure of these pep-
tides [33].
Biological activities
The biological activities of all MK  analogue peptides were
investigated by assaying mast cell degranulation, hemolysis, and
antimicrobial activities. Fig. 4 shows the results for rat peritoneal
mast cell degranulation. Peptide HRII was used as the standard for
mast cell degranulation [1,2]. Analogues MK89 and MK9  presented
the highest degranulation activity, while all the other analogues
presented greatly reduced degranulation activity.
The hemolytic activity on rat erythrocytes is shown in Fig. 5A and
B. Peptides MK5, MK89, MK9, and MK58911 presented the highest
hemolytic activity amongst all the MK  analogs. Curiously, all the
remaining peptides presented reduced hemolytic activities despite
their large differences in net charge and hydrophobicity.
The antibiotic assays against Gram-positive and Gram-negative
bacteria were performed for all ten MK analog peptides, and
the results are summarized in Table 3. It may  be observed that
peptides MK4589, MK45789, and 4578911 were highly active
against the Gram-negative bacteria, especially MK4589, which
was more potent that the reference antibiotic, chloramphenicol.
B.M.d. Souza et al. / Peptides 72 (2015) 164–174 169
Fig. 2. CID MS  spectra of MK578, acquired under continuous infusion of the peptide solution into the mass spectrometer. Each spectrum represents the combination of
scans  within 1 min  of data acquisition: (A) peptide in water in the absence of D2O (monoisotopic molecular ion at m/z  1584.0 as [M + H]+); (B) peptide as proteoliposomes
(LUVs) with PC in the presence of D2O (monoisotopic molecular ion at m/z 1592.7 as [M + H]+; and (C) peptide as proteoliposomes (LUVs) with PCPG in the presence of D2O
(monoisotopic molecular ion at m/z  1593.2 as [M + H]+; The mass differences between the consecutive bn ions and their correspondence to the deduced amino acid sequences
are  shown. The black dots (•) assigned over the symbols of certain amino acid residues correspond to the location of deuterons at speciﬁc amide hydrogens.
Table 3
Antibiotic activity of MK analog peptides against Gram-positive and Gram-negative bacteria, expressed as minimum inhibitory concentration (MIC).
MIC  (g/mL)
MK578 MK89 MK9  MK5  MK0  MK4589 MK5789 MK58911 MK45789 MK4578911 Chloramphenicol
Gram-negative
E. coli (CCT 1457) 31 4 250 31 >500 1 8 4 4 1 1
E.  coli (ATCC 11775) 63 8 500 500 >500 4 31 16 4 16 4
E.  coli (ATCC 25922) 23 4 250 125 >500 4 31 31 16 16 1
P.  aeruginosa (ATCC15442) 125 16 500 31 >500 8 125 16 8 16 16
P.  aeruginosa (ATCC13388) 250 63 500 500 >500 16 250 8 4 16 31
S.  choleraesuis (ATCC10708) 500 16 500 500 >500 8 500 31 31 31 8
S.  typhimurium (ATCC14028) 500 31 500 500 >500 2 31 8 4 8 8
Gram-positive
S.  aureus (CCT 2580) 43 4 4 1 >500 2 8 4 2 2 1
S.  aureus (CCT 6538) 63 4 16 250 >500 1 31 8 4 63 16
S.  aureus (ATCC 25923) 63 8 16 250 >500 2 2 4 2 2 8
S.  epidermides (ATCC12228) 63 4 16 63 >500 1 4 2 1 1 16
S.  pneumoniae (ATCC11733) 125 2 1 2 >500 1 2 1 1 1 8
S.  mutans (AU159) 500 4 250 500 >500 2 4 8 4 16 16
B.  cereus (ATCC11778) 16 16 125 125 >500 16 250 31 31 125 4
B.  thuringiensis (ATCC10792) 125 8 125 125 >500 31 125 31 31 125 8
E.  faucium (CCT5079) 250 8 250 500 >500 1 8 1 2 2 2
E.  hirae (ATCC10541) 63 8 250 500 >500 8 31 16 31 63 2
R.  equi (ATCC25729) 250 4 250 250 250 1 2 2 2 8 16
M.  luteus (ATCC4698) 31 4 15.6 125 >500 1 4 2 1 1 16
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Fig. 3. Schematic representation of peptide/membrane interaction obtained from
proteoliposome H/D exchange assay combined with ESI–MS/MS mass spectrometry
for all mastoparan analogs of the MK series in the presence of PC (A) and PCPG (B)
vesicles. The gray region represents the inner side of the membrane. The black dots
(•) represent deuterium labeled sites. Thus, residues identiﬁed with a black dot
are  positioned outside the vesicle membrane, while residues embedded into the
membrane lack the black dot in the grey region.
Fig. 4. Mast cell degranulation activity in rat peritoneal mast cells. The activity was
determined by measuring the release of the granule marker, -d-glucosaminidase,
which co-localizes with histamine, and the values for -d-glucosaminidase released
in  the medium were expressed as a percentage of total -d-glucosaminidase. Values
are mean ± S.D. (n = 5). (A) shows the proﬁles of activities of the standard peptide
HR II and the mastoparan analogs MK89, MK578, and MK4589, while (B) shows
the activities of the analogs MK0, MK5, MK9, MK5789, MK58911, MK45789, and
MK4578911.
Fig. 5. Hemolytic activity in washed rat red blood cells (WRRBC). The absorbance
measured at 540 nm from lysed WRRBC in the presence of 1% (v/v) Triton X-100
was considered as 100%. Values are mean ± S.D. (n = 5). (A) shows the activity pro-
ﬁles of mellitin (standard peptide) and the mastoparan analogs MK89, MK578, and
MK4589, while (B) shows the activities of mellitin and the analogs MK0, MK5, MK9,
MK5789, MK58911, MK45789, and MK4578911.
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eanwhile, the mastoparan analogs MK89, MK4589, MK45789,
nd MK4578911 were very active against the eleven different
pecies of Gram-positive bacteria, especially peptide MK4589,
hich again was more active than the reference antibiotic com-
ound chloramphenicol.
iscussion
Mastoparan peptides usually perform their roles in vertebrates
oth through the activation of mast cell exocytosis, delivering
he granule contents to the media, especially histamine, and by
erturbing erythrocyte membranes, leading to hemolysis [30].
ast cell degranulation may  occur by mastoparan binding to
he extracellular receptor of G subunit of a trimeric G-protein
ontrolling the exocytosis process, and in addition, some of
hese peptides can penetrate into mast cells and activate both
he Ca2+-independent and Ca2+-dependent FcRI-mediated exo-
ytosis pathways to enhance the potency of the inﬂammatory
ctions caused by the mastoparans as toxins [16,17,28,32,35]. Thus,
astoparan peptides seems to play their roles in mast cells through
irect binding to speciﬁc receptors at the extracellular cell sur-
ace and/or at the level of endosomal receptors, which requires
he recognition of a well-deﬁned secondary structure of the ligand
mastoparan) by the receptors. It is not clear what structural and/or
hysicochemical factors regulate the ligand-receptor afﬁnity for
astoparans.
Mastoparan peptides can also cause erythrocyte lysis, leading
o hemolysis; apparently, the mastoparans interact with the zwit-
erionic membrane of these cells through the “carpet” mechanism,
ausing pore formation and structural perturbations that lead to
ytolysis [29,34]. For this reason, mastoparans have been used as
odels for the development of AMPs [4,11,15,40,41]. A series of
ublications have reported the contributions of different physic-
chemical parameters to the optimization of the antimicrobial
ctivity of mastoparans and/or the minimization of other parallel
ctivities; however, there is no rational panel of factors explain-
ng the interaction between mastoparans and animal and bacterial
ell membranes. The mastoparan Polybia-MP I presented an anti-
ancer effect (both in vitro and in vivo) against prostate tumor and
eukemic cells but presented no effect against healthy cells [36];
he apparent selectivity for tumorigenic cells was attributed to the
resence of phosphatidylserine in the outer leaﬂet of these cells,
hich is generally absent in healthy cells [37]. This explanation was
atter corroborated, demonstrating that the high content of anionic
ipids in the membranes increases the level of binding of the peptide
o bilayers, favoring the anti-cancer effect of mastoparans [11]. It
as also reported that mastoparans cause gradual cell leakage due
o their accumulation on the membrane surface, inducing a tran-
ient interruption of its barrier properties and the leakage of cell
ontents. The membrane recovers its continuity inhomogeneously,
reating a type of ply with peptides sandwiched between the jux-
aposed faces of the membranes. Periodically, a peptide and lipid
ggregate together, forming a lump with a high peptide-to-lipid
atio [10]. In relation to the actions of AMPs, a substitution library
f a dodecapeptide derived from bactenecin was created, which
emonstrated that certain positions in the peptide sequences are
ore sensitive to substitution than others and that the introduc-
ion of certain amino acid residues, particularly charged ones, can
roduce peptides with increased antimicrobial activity [18]. Using
odel AMPs composed only of Leu and Lys residues, Kim and Cha
19] synthesized a series of peptides presenting different cationic
istributions, demonstrating that the dispersion of cationic amino
cid residues on the hydrophilic surface is a factor that contributes
o the antimicrobial activity. De Souza et al. [5] reported that the
ntimicrobial activities of mastoparan peptides bearing positives 72 (2015) 164–174 171
charges at the positions 4/5 and/or from 11 to 13 were highly
active, while peptides presenting positive charges located in the
middle of peptide chain exhibited reduced activity. It was sug-
gested that the positioning of the Lys residues at those strategic
sites was  ﬂanking and maintaining a stable helical segment, result-
ing in a more homogeneous hydrophobic surface in an amphipathic
structure, contributing in turn to the maximal lytic efﬁciency of
the mastoparans. At the same time, Leite et al. [22] demonstrated
the interplay between net charge and mean hydrophobicity, work-
ing with similar mastoparan peptides. These studies stimulated the
further investigation of the contributions of the number and posi-
tioning of Lys residues along the peptide chain; thus, a series of
novel mastoparan analogs was engineered based on the rationale
of reducing the number of hydrophobic residues in the hydrophilic
face of the peptides molecule. This approach permitted investiga-
tion of the effects of the number and location of the residues of Lys
in the peptide chain, as well as the inﬂuence of the net charge at
physiological pH, mean hydrophobicity, and hydrophobic moment,
on the biological activities of the mastoparan analogs (mast cell
degranulation, hemolysis, and antimicrobial action).
Structural characterization of MK  analogs
Typically, mastoparans present three Lys residues at positions
4/5 and/or 11/12 [4,5,26,27,39,40]; an interesting exception is the
peptide EMP-AF, in which the Lys residues are at positions 5, 9 and
12 [7]. The series of mastoparan analogs synthesized resulted in
peptides presenting from zero to six Lys residues, with net positive
charges from +1 to +7, mean hydrophobicities from −0.280 to 0.319,
and hydrophobic moments from 0.072 to 0.279 (Table 1).
The CD spectroscopy analysis revealed that all the peptides pre-
sented random coil as their secondary structure in the presence
of water. Meanwhile, in the presence of 40% (v/v) TFE and 8 mM
SDS, the peptide with no Lys residue in its sequence (MK0) has
no -helix in its secondary structure; all the other MK  peptides
presented from 42 to 69% -helix in their secondary structures
(Table 2). Regarding interaction with membrane mimetic-systems,
the CD data in the presence of anionic PC vesicles showed that only
the analogs MK89, MK9, and MK5  presented some fraction of -
helix in their secondary structure (from 18 to 37%). However, in
the presence of zwitterionic PCPG vesicles, the peptides MK0  and
MK4578911 (presenting zero and six Lys residues, respectively)
presented only -turn-like secondary structure, while the other
MK analogs presented from 19 to 42% -helix in their secondary
structures (Table 2).
The helical wheel representation of the ten MK  analogs is shown
in Fig. 6, where it is possible to observe the increasing hydrophilic
surface of the peptides as the number of Lys residues increases
along their sequence. It is important to emphasize that this type
of representation is purely hypothetical, as the whole secondary
structures of all peptides are considered 100% helical. This supposi-
tion is not completely true, as the CD data (Table 2) reveal that only
in the presence of 40% (v/v) TFE do all the peptides present some
level of helicity (from 31 to 65%). The hydrophilic surfaces were
initially considered to extend from the N-terminal residue (which
becomes protonated at physiological pH) to the residue Asn 2; this
surface contains ﬁve amino acid residues, three of them hydropho-
bic (in the peptide MK0). The introduction of Lys residues into this
surface (at positions 5 or 9) contributed to making this surface
more positive, as reﬂected in the decreasing mean hydrophobic-
ity values and increasing hydrophobic moments (see Table 1). The
replacements of certain hydrophobic residues at positions 7, 8, 9,
and 11 resulted in a large increase in the hydrophilic surface (Fig. 4),
with a consequent decrease in the mean hydrophobicity values per
residue. Thus, the decreasing order of the hydrophilic surface for
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he mastoparan MK  analogs is as follows: MK4578911, MK45789,
K578 > MK58911, MK5789 > MK4589 > MK89 > MK0, MK5, MK9.
he interaction of mastoparan MK  analogs with
embrane-mimetic system
The H/D exchange experiments were performed under non-lytic
onditions, i.e., with [P]/[L] = 1/100. Thus, the experiment permit-
ed the visualization of peptide movements on vesicle membranes
t different times without membrane rupture. The positioning
f each peptide at different times of incubation is schematized
n Fig. 3; the interpretation of these schemes suggests that each
odel proposed at a different time of incubation represents a
napshot of a time course experiment (60 min) initiated by the
ddition of the peptides to water and in the presence of the vesi-
les; under this condition, the peptides were randomly coiled (as
emonstrated in Table 2). After a short time, the peptide inter-
cts with the lipid membrane in a position more-or-less parallel
o the LUV surfaces. The positioning of the amide bonds pro-
ected from H/D exchange in the core of the membrane indicates
hat one or more peptide populations were partially adsorbed
o the vesicles. These populations are characterized by different
ypes and numbers of contacts with the membranes and are not
frozen”; throughout the incubation time; these populations of
eptides change their positioning in relation to the membrane to
chieve more energetically favorable conformations. Thus, the pep-
ide molecules may  eventually diffuse on the membrane surface
uring the course of the experiment. Careful observation of the
eptide–membrane interaction models proposed in Fig. 3 reveals
he unusual insertion of charged side-chains of Lys residues into
he hydrophobic core of the membrane, which causes membrane
estabilization, contributing to the occurrence of frequent confor-
ational changes in the peptide chain. Thus, considering that the
-termini of all peptides remain positioned outside the membrane
uring most of the incubation time course, the frequent confor-
ational changes in the remaining regions of the peptide chain
ould contribute to the bilayer destabilization. Under the condi-
ions described above, some regions of the membranes reaches a
ritical concentration of peptides, followed by the consequent leak-
ge of vesicles. The results above support the hypothesis that the
nteraction of the synthetic mastoparan peptides (MK  analogs) with
C and PCPG membranes occurs basically through the carpet model.
herefore, the peptide adsorbs on the membrane surface, forming
artially helical structures, which insert some parts of the -carbon dashed lines delimiting the curved line represent the hydrophilic surface of each
backbone into the core of the membrane, changing the confor-
mation constantly but always maintaining its positioning roughly
parallel to the external surface of the membrane. The position-
ing of the -carbon partially embedded into the membrane core
with frequently changing conformations must cause membrane
destabilization and leakage of the vesicle contents. Considering the
number of amino acid residues embedded into the membrane core
as a criteria for evaluating peptide–membrane interaction, peptides
MK7, MK89, MK4589, and MK58911 present the highest numbers
of contacts with the core of the anionic (PC) membranes and there-
fore are expected to present the highest hemolytic activity amongst
the mastoparan MK  analogs. Meanwhile, the peptides MK4589,
MK4578911, and MK45789 interact more strongly with the zwitte-
rionic (PCPG) membranes (Fig. 3A and B) and therefore are expected
to present the highest antibiotic activity.
Structure–activity relationship for the MK analog peptides
This study focuses on the structure–activity relationship of
mastoparan-like peptides by varying the number and positioning
of Lys residues along the peptide chain. Nevertheless, this varia-
tion also causes simultaneous changes in the mean hydrophobicity
of the peptides as well as in other structural parameters, such as
the hydrophobic moment, the size of the polar face and the overall
amphipathicity.
It is important to emphasize that the mast cell degranulation
activity is directly dependent on the interaction of the peptides with
a membrane coupled G-protein receptor; this interaction requires a
perfect ﬁt of the secondary structure of the peptide with its binding
site to the G sub-unit of the G-protein [17,28]. As peptides MK9
and MK89 were the most active analogs in relation to mast cell
degranulation, it seems that the positioning of Lys residues at posi-
tions 8 and/or 9 is important for the correct binding of the peptides
(ligands) to the binding site at the G sub-unit.
The hemolytic activity seems to be directly dependent on
the membrane perturbation caused by the peptides due to their
interaction with the zwitterionic membrane of the erythrocytes.
The most active hemolytic peptides assayed were the analogs
MK9, MK89, MK58911, and MK5. These peptides present from one
to four Lys residues, with hydrophobicity values changing from
0.126 to −0.067 and hydrophobic moments changing from 0.163 to
0.243; it is difﬁcult to correlate these variables with the hemolytic
potency of the peptides, as they are distributed in a large range of
values. If the total number of amino acid residues of each peptide
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mbedded into the membrane core (as seen in Fig. 3) is considered
o explain the intensity of membrane perturbation, it would be easy
o explain the activities of peptides MK9, MK89, and MK58911,
ut this argument would not justify why peptide MK5  is so active
nd why MK4589 is poorly hemolytic. However, if the number of
mino acid residues from the C-terminal region of each peptide
hat are continuously embedded into the membrane of PC vesicles
Fig. 3A) is used as a criterion to evaluate the extent of membrane
erturbation of the zwitterionic membranes, there is a strongly
orrelation with the intensity of hemolysis. Peptides MK9, MK89,
K58911, and MK5  present the highest number of amino acid
esidues in the C-terminal regions of their respective molecules
ontinuously embedded into the membrane core, amongst all the
K analogs.
If the apparent extent of the hydrophilic or hydrophobic surface
f each peptide shown in Fig. 6 is used as a criterion to explain
he hemolytic potency of the MK  analog peptides, no correlations
re observed, because the most active peptides include molecules
resenting large hydrophilic surfaces (MK578) as well as peptides
ith reduced hydrophilic surfaces (MK5, and MK9).
The assays of antibiosis revealed that the peptides MK4589,
K45789, and MK4578911 presented a wide spectrum of activity,
ith very potent action against both Gram-positive and Gram-
egative bacteria, being more active even than chloramphenicol.
 general physicochemical feature of these peptides is that they
resented from four to six lysine residues in their sequences, with
ve to seven net positive charges, mean hydrophobicity values from
0.087 to −0.280, and hydrophobic moments ranging from 0.072 to
.248. A careful observation of the schemes of peptide–membrane
nteraction with the anionic PCPG vesicles (which mimic  bacte-
ial cells) shown in Fig. 3B reveals that these peptides have the
ighest number of amino acid residues embedded into the mem-
rane core (from eight to nine), suggesting that they must interact
ore strongly with the bacterial membrane than the remaining MK
nalogs.
Amongst the mastoparans of the MK  series, the analogs pre-
enting the most potent antibiotic activities have the largest
pparent hydrophilic surfaces, i.e., the highest numbers of Lys
esidues. This correspondence is most likely related to the neu-
ralization of the anionic character of the PCPG vesicles by the
ighly cationic characteristics of the MK4589, MK45789, and
K4578911 analogs, favoring the deeper interaction of these pep-
ides with the bacterial membranes compared to the analogs with
ewer Lys residues in their sequences. The MIC  values of these
eptides against Gram-negative and Gram-positive bacteria are
pproximately 16 g/mL, while the value for mastoparan-AF is
30 g/mL [23], and for the peptide anoplin the value ranges
rom 25 to 50 g/mL [21]. Therefore, the antimicrobial activity
f the peptides MK4589, MK45789, and MK4578911 is very high
ompared to other peptides that are considered to be highly
ctive.
onclusion
The initial rationale for engineering mastoparan analog pep-
ides was based on the replacement of certain hydrophobic residues
n the hydrophilic face of the peptide molecules by Lys residues.
he effects of two different residue replacement strategies were
nvestigated: (i) the individual replacement of Lys residues by
la, one by one, in a type of Ala scan; and (ii) the replace-
ent of Leu or Ala residues by Lys, in a type of Lys scan. Thesetrategies resulted in a series of peptides presenting net positive
harges from +1 to +7, different values of mean hydrophobicity
er residue, and different hydrophobic moments. Thus, 10 syn-
hetic mastoparans, tetradecapeptides amidated at their C-termini,s 72 (2015) 164–174 173
were assayed for some typical biological activities for this group
of peptides: mast cell degranulation, hemolysis, and antibio-
sis.
Considering that the mast cell degranulation depends on the
ligand (peptide)-receptor (G sub-unit of a G-protein), the appar-
ent structural requirement for optimizing this activity was the
existence of one or two  Lys residues at positions 8 and/or 9. It
was difﬁcult to establish a relationship between this activity and
the biophysical parameters, namely the mean hydrophobicity per
residue and hydrophobic moments.
Regarding hemolysis, one structural aspect that that seems to
be strongly correlated with the potency of this activity is the num-
ber of amino acid residues from the C-terminus of each peptide
that are continuously embedded into the zwitterionic membrane
of erythrocytes, probably due to the contribution of this structural
feature to the membrane perturbation.
The antibiotic activity of the engineered mastoparan MK  analogs
seems to be directly dependent on the apparent extension of their
hydrophilic surface, i.e., their molecules must have from four to
six Lys residues between positions 4 and 11 of the peptide chain
to achieve activities comparable to or higher than the reference
antibiotic compounds.
Therefore, to optimize the antibacterial activity of mastoparans,
it is important have Lys residues at positions 4, 5, 7, 8, 9, and 11
of the tetradecapeptide chain, with the other positions occupied
by hydrophobic residues, and with the C-terminal residue in the
amidated form. These criteria resulted in highly active AMPs, with
highly reduced (or no) hemolytic and mast cell degranulating activ-
ities.
Conﬂict of interest statement
The authors declare no conﬂict interest.
A few words about Abba Kastin
The recognition of Abba Kastin on the occasion of his retire-
ment as Editor-in-chief of PEPTIDES is an auspicious occasion in
the academic history of peptide research abroad. During 35 years
Abba fought to provide an internationally recognized vehicle to dis-
seminate scientiﬁc results about the structure and activity of all
types of biologically active peptides. The permanently open mind
of Abba Kastin made him always ready to accept new challenges
in peptide research, expanding the borders of the “peptidology”,
paving the way  for all of us to have access to a high level generalist
peptide journal. The books he edited/wrote, especially the well-
known editions of “Handbook of Biologically Active Peptides” have
tremendous importance and became very popular in peptide sci-
ence because they presented updated information in a wide range
of topics, in a style eminently readable. Ten years serving as mem-
ber of the Editorial Board gave me  pleasant opportunities to discuss,
and to share many different scientiﬁc and technical aspects of the
editorial board with him. During this time I learned to appreciate
some aspects of his personality, such as the talent to identify and
honor the merits and the skills of the colleagues. With his very
enthusiastic way  Abba attracted us to publish the results of our
research about insect venom toxins in PEPTIDES, which in turn
attracted many other toxinologists abroad to do the same. Abba:
every time you came to Brazil for lectures, you created a legion
of admirers in our scientiﬁc community due to your extraordinary
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